Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model

Fig. 4

Kaplan–Meier survival curves of IC + CCRT and CCRT+AC patients classified as high risk for treatment failure according to a novel risk scoring system. Patients in the IC + CCRT group achieved better 3-year overall survival (OS) and 3-year distant failure-free survival (DFFS) (both P < 0.05 by rank-sum test). IC = induction chemotherapy. AC = adjuvant chemotherapy

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us